Joinn Laboratories(China)Co.,Ltd. (SHA:603127)

Market Cap	11.04B
Revenue (ttm)	2.02B
Net Income (ttm)	74.08M
Shares Out	733.37M
EPS (ttm)	0.10
PE Ratio	160.70
Forward PE	52.04
Dividend	0.16 (0.99%)
Ex-Dividend Date	Jul 31, 2024

Volume	12,748,587
Average Volume	22,255,278
Open	16.03
Previous Close	16.07
Day's Range	15.81 - 16.08
52-Week Range	12.32 - 23.48
Beta	0.73
RSI	42.78
Earnings Date	Apr 28, 2025

About SHA:603127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I cli...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 2,510
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603127

Financial Performance

In 2024, SHA:603127's revenue was 2.02 billion, a decrease of -15.07% compared to the previous year's 2.38 billion. Earnings were 74.08 million, a decrease of -81.34%.